Clinical Trial Update: Lopinavir/Ritonavir (Kaletra) PK in Children [Phase 4]

View source ↗

Summary

Phase 4 study assessing the pharmacokinetics of lopinavir/ritonavir (Kaletra) in children with HIV/AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: HIV/AIDS Treatment, HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2012-07-06